Tiedemann Advisors’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-25,000
Closed -$723K 308
2021
Q2
$723K Hold
25,000
0.03% 198
2021
Q1
$658K Hold
25,000
0.03% 193
2020
Q4
$716K Hold
25,000
0.03% 178
2020
Q3
$596K Hold
25,000
0.03% 213
2020
Q2
$523K Hold
25,000
0.03% 211
2020
Q1
$448K Buy
+25,000
New +$482K 0.03% 210

Other funds holding BMEZ

Tiedemann Advisors's BMEZ Position: Q3 2021 in Review

Tiedemann Advisors sold out of BlackRock Health Sciences Trust II (BMEZ) in Q3 2021, closing a stake of 25,000 shares — an estimated $723K sold.

Tiedemann Advisors first reported a position in BMEZ in Q1 2020 and held it in 6 quarters. The position peaked at $723K in Q2 2021. 67 funds tracked by Wall St. Rank hold BMEZ as of Q3 2021.

  • Tiedemann Advisors reported no remaining BlackRock Health Sciences Trust II position as of Q3 2021 after selling out during the quarter.
  • Tiedemann Advisors sold 25,000 BlackRock Health Sciences Trust II shares in Q3 2021, an estimated $723K.
  • Tiedemann Advisors first reported a position in BlackRock Health Sciences Trust II in Q1 2020 and held it in 6 quarters.
  • Tiedemann Advisors's BlackRock Health Sciences Trust II position peaked at $723K in Q2 2021.
  • 67 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q3 2021.

Based on Tiedemann Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.